This is an outdated version published on 2022-09-28. Read the most recent version.

Acceptance of COVID-19 Vaccine Among Unvaccinated Filipinos

Authors

DOI:

https://doi.org/10.5195/ijms.2022.1192

Keywords:

COVID-19 Vaccines, Patient Acceptance of Health Care, Social Determinants of Health, Philippines

Abstract

Background: Access to COVID-19 vaccines was one of the global measures for containing the COVID-19 pandemic. However, it is still not known whether Filipinos accept it.

 Methods: Cross-sectional study based on a modified version of the community COVID-19 vaccine acceptance survey, disseminated and collected through Google Forms to Filipinos within the Philippines aged 18-65 years old. Multinomial logistic regression analysis was performed to determine the association between the willingness to be vaccinated and sociodemographic characteristics using odds ratios (OR) with 95% confidence intervals (95%CI).

 Results: Among the 1,011 participants, 79.5% were willing to accept the COVID-19 vaccine. Significant determinants (p<0.05) were age, region of residence, sex, profession, income, religion, practice of alternative medicine, and previous contact with COVID-19 positive individuals. Essential healthcare workers (OR=11.0, 95%CI=1.3-93.5), practiced alternative medicine (OR=2.4, 95%CI=1.3-4.4), with previous contact with a COVID-19 positive person (OR=2.9, 95%CI=1.4-6.0), and females>males (OR=0.6, 95%CI=.3-1.0) were also more likely to accept COVID-19 vaccination. 63.7% preferred Pfizer the most, and 54.4% preferred Sinovac the least. In contrast, married individuals, essential non-healthcare workers and private/self-employed sectors were less likely to accept COVID-19 vaccines. Many individuals who refused to be vaccinated were unsure of its safety (59.70%) and had no trust in vaccines (56.50%).

Conclusion: Despite a high prevalence of acceptance of the COVID-19 vaccine in our study, there were significant sociodemographic disproportions in vaccine acceptance. Better policies urging Filipinos to get vaccinated and more effective dissemination of unified information regarding vaccines from verified sources are recommended to boost vaccine confidence in the Philippines.

Metrics

Metrics Loading ...

References

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Available from: https://covid19.who.int/; Updated January 24, 2021; cited January 24, 2021

Islam M, Rahman K, Sun Y, Qureshi M, Abdi I, Chughtai A et al. Current knowledge of COVID-19 and infection prevention and control strategies in healthcare settings: A global analysis. Infection Control & Hospital Epidemiology. 2020;41(10):1196-1206. DOI: https://doi.org/10.1017/ice.2020.237

Richardson SJ, Carroll CB, Close J, Gordon AL, O’Brien J, Quinn TJ, et al. Research with older people in a world with COVID-19: identification of current and future priorities, challenges and opportunities. Age Ageing. 2020;49(6):901–6. DOI: https://doi.org/10.1093/ageing/afaa149

Gagneux-Brunon A, Detoc M, Bruel S, Tardy B, Rozaire O, Frappe P et al. Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross-sectional survey. Journal of Hospital Infection. 2021;108:168-173. DOI: https://doi.org/10.1016/j.jhin.2020.11.020

Food and Drug Administration of the Philippines. FDA Circular No. 2020-036 || Guidelines on the Issuance of Emergency Use Authorization for Drugs and Vaccines for COVID-19. Available from: https://www.fda.gov.ph/fda-circular-no-2020-036-guidelines-on-the-issuance-of-emergency-use-authorization-for-drugs-and-vaccines-for-covid-19/; Updated December 2020; cited January 15, 2021

Rodrigues CM, Plotkin SA. Impact of Vaccines; health, economic and social perspectives. Frontiers in Microbiology. 2020Jul14;11. DOI: https://doi.org/10.3389/fmicb.2020.01526

Office of the Presidential Spokesperson. On the SWS survey on COVID-19 vaccine. Available from: https://pcoo.gov.ph/OPS-content/on-the-sws-survey-on-covid-19-vaccine/; Updated Novemberr 20, 2020; cited 24 January 24, 2021

Lazarus J, Ratzan S, Palayew A, Gostin L, Larson H, Rabin K et al. A global survey of potential acceptance of a COVID-19 vaccine. Nature Medicine. 2020;27(2):225-228. DOI: https://doi.org/10.1038/s41591-020-1124-9

Malik A, McFadden S, Elharake J, Omer S. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020 ;26:100495. DOI: https://doi.org/10.1016/j.eclinm.2020.100495

Shekhar R, Sheikh AB, Upadhyay S, Singh M, Kottewar S, Mir H, et al. COVID-19 vaccine acceptance among health care workers in the United States. 2021;9(2):119. DOI: https://doi.org/10.3390/vaccines9020119

Sallam M. COVID-19 vaccine Hesitancy Worldwide: A CONCISE systematic review of VACCINE acceptance rates. Vaccines. 2021;9(2):160. DOI: https://doi.org/10.3390/vaccines9020160

Harapan H, Wagner A, Yufika A, Winardi W, Anwar S, Gan A et al. Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Frontiers in Public Health. 2020;8. DOI: https://doi.org/10.3389/fpubh.2020.00381

Department of Health. PH Receives First Batch of Government-Procured Vaccines. Available from: https://doh.gov.ph/doh-press-release/PH-RECEIVES-FIRST-BATCH-OF-GOVERNMENT-PROCURED-VACCINES; Updated March 29, 2021; cited July 8, 2021

Octa Research. Only 1 out of 5 Filipinos willing to be inoculated with COVID-19 vaccine. Available from: https://cnnphilippines.com/news/2021/2/25/one-in-five-filipinos-willing-vaccinated.html?fbclid=lwAR2; Updated February 25, 2021; cited June 10, 2021

Social Weather Stations. First Quarter 2021 Social Weather Survey: 51% of adult Filipinos are confident, 17% are not confident about the government's evaluation of Covid-19 vaccines. Available from: https://www.sws.org.ph/swsmain/artcldisppage/?artcsyscode=ART-20210520103851; Updated May 20, 2021; cited July 5, 2021

Philippine Statistics Authority. Mapa. Functional Literacy Rate is Estimated at 91.6 Percent in 2019. Available from: https://psa.gov.ph/content/functional-literacy-rate-estimated-916-percent-2019; Updated December 11, 2020; cited July 10, 2021

Kabir R, Mahmud I, Chowdhury MT, Vinnakota D, Jahan SS, Siddika N, et al. COVID-19 vaccination intent and willingness to pay in Bangladesh: A cross-sectional study. Vaccines. 2021;9(5):416. DOI: https://doi.org/10.3390/vaccines9050416

Department of Health. COVID-19 Case Tracker. Available from: https://doh.gov.ph/2019-nCoV; Updated June 6, 2021; cited June 10, 2021

Wong L, Alias H, Wong P, Lee H, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Human Vaccines & Immunotherapeutics. 2020;16(9):2204-2214. DOI: https://doi.org/10.1080/21645515.2020.1790279

National Wages and Productivity Commission. Daily Minimum Wage Rates. Available from: https://nwpc.dole.gov.ph/; Updated May 2021; cited June 10, 2021

Stanford Graduate School of Business. The Behavioral Impact of a Higher Price. Available from: https://www.gsb.stanford.edu/insights/behavioral-impact-higher-price; Updated March 1, 2008; cited July 10, 2021

Yeo HY, Shafie AA. The acceptance and willingness to pay (wtp) for hypothetical dengue vaccine in Penang, Malaysia: A Contingent Valuation study. Cost Effectiveness and Resource Allocation. 2018;16(1). DOI: https://doi.org/10.1186/s12962-018-0163-2

Borriello A, Master D, Pellegrini A, Rose JM. Preferences for A COVID-19 vaccine in Australia. Vaccine. 2021;39(3):473–9. DOI: https://doi.org/10.1016/j.vaccine.2020.12.032

BioSpace. UPDATED Comparing COVID-19 Vaccines: Timelines, Types and Prices. Available from: https://www.biospace.com/article/comparing-covid-19-vaccines-pfizer-biontech-moderna-astrazeneca-oxford-j-and-j-russia-s-sputnik-v/; Updated July 28, 2021; cited July 30, 2021

Wouters O, Shadlen K, Salcher-Konrad M, Pollard A, Larson H, Teerawattananon Y et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. The Lancet. 2021;397(10278):1023-1034. DOI: https://doi.org/10.1016/S0140-6736(21)00306-8

Bond L, Nolan T. Making sense of perceptions of risk of diseases and vaccinations: A qualitative study combining models of health beliefs, decision-making and risk perception. BMC Public Health. 2011;11(1). DOI: https://doi.org/10.1186/1471-2458-11-943

World Health Organization. Report of the Sage Working Group on Vaccine Hesitancy. Available from: https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf; Updated October 2014; cited June 10, 2021

Migriño, Jr. J, Gayados B, Birol K, De Jesus L, Lopez C, Mercado W et al. Factors affecting vaccine hesitancy among families with children 2 years old and younger in two urban communities in Manila, Philippines. Western Pacific Surveillance and Response Journal. 2020;11(2):20-26. DOI: https://doi.org/10.5365/wpsar.2019.10.2.006

Silver L, Smith A, Johnson C, Jiang J, Anderson M, Rainie L. Use of smartphones and social media is common across most emerging economies]. Pew Research Center: Internet, Science & Tech. 2019. Available from: https://www.pewresearch.org/internet/2019/03/07/use-of-smartphones-and-social-media-is-common-across-most-emerging-economies/; Updated March 7, 2019; cited June 10, 2021

Talwar S, Dhir A, Singh D, Virk G, Salo J. Sharing of fake news on social media: Application of the honeycomb framework and the third-person effect hypothesis. Journal of Retailing and Consumer Services. 2020;57:102197. DOI: https://doi.org/10.1016/j.jretconser.2020.102197

Downloads

Published

2022-05-03 — Updated on 2022-09-28

Versions

How to Cite

Pagador, P., Pacleb, A., Ormita, M. J., Valencia, F. E., Velasco, D. H., & Josue-Dominguez, R. (2022). Acceptance of COVID-19 Vaccine Among Unvaccinated Filipinos. International Journal of Medical Students, 10(3), 264–276. https://doi.org/10.5195/ijms.2022.1192

Issue

Vol. 10 No. 3 (2022)

Section

Original Article

Categories

License

Copyright (c) 2022 Pamela Pagador, Adrienne Pacleb, Mikaela Joy Ormita, Frances Eleane Valencia, Danz Harvey Velasco, Rosemarie Josue-Dominguez

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
    2. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
    3. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
    4. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
    5. The Author represents and warrants that:
      1. the Work is the Author’s original work;
      2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
      3. the Work is not pending review or under consideration by another publisher;
      4. the Work has not previously been published;
      5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
      6. the Work contains no libel, invasion of privacy, or other unlawful matter.
    6. The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Enforcement of copyright

The IJMS takes the protection of copyright very seriously.

If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.

If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org

 

Infringing material

If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org